Please confirm that you would like to log out of Medscape.
If you log out, you will be required to enter your username and password the next time you visit.
Log outCancel
Might the intense psychosocial stress associated with a novel, potentially fatal disease along with lockdown restrictions be a trigger for first-episode psychosis?
This review examines the similarities and differences between hallucinations under psychedelics and in the schizophrenia-spectrum disorders, from both physiological and phenomenological perspectives.
This review highlights key issues for the clinician caring for older adults with hallucinations. How is assessment, management, and treatment best approached?
This study aimed to examine associations between dissociation and the full range of psychosis symptomatology. Might some psychotic symptoms be better conceptualized as dissociative in nature?
The COVID-19 pandemic may place a disproportionate burden on persons with schizophrenia, including an increased risk of infection and possible mental health consequences if infected.
This study aimed to describe how patients with schizophrenia experience anomalies of lived space, focusing on their perception of space, objects, and other human bodies.
Using a patient example, this article focuses on the need for building trust and applying caring cognitive behavioral talking skills when communicating with people who suffer from a psychosis.
Might Epstein-Barr virus infection contribute to the immunopathology of schizophrenia? This study found that individuals with schizophrenia have increased levels of antibodies to certain EBV proteins.
This study suggests that potent D2 antagonists diminish the reward-enhancing effects of nicotine in smokers with schizophrenia, which may explain the increased rate of smoking in these patients.
This study used GWAS statistics to investigate the genetic relationship between schizophrenia and breast cancer. Do these two diseases share genetic risk factors?
This RCT contrasted two types of single-session interventions for serious mental illness, augmented by a mobile health app: cognitive behavioral therapy vs. illness education with self-monitoring.
This Cochrane review evaluated the current evidence for the efficacy of electroconvulsive therapy on clinical response for people with treatment-resistant schizophrenia.
The author, a schizophrenic, relates her experiences with the mental health system and her frustrations at lapses in communication and a lack of triage services.
This study demonstrated the efficacy of individualized metacognitive training, a novel psychotherapy designed to specifically target delusional beliefs in people with psychosis.
